Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $1.33 0.1600 +13.68%
CBMG $27.11 2.3400 +9.45%
NYMX $2.72 0.1500 +5.84%
GALE $1.70 0.0900 +5.59%
MEIP $1.65 0.0800 +5.10%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.10 -0.0700 -41.18%
IMMU $2.11 -0.4400 -17.25%
PGNX $8.43 -0.9900 -10.51%
IMDZ $21.04 -2.0100 -8.72%
MDVN $95.74 -8.7700 -8.39%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

Biocept Launches Diagnostic Assay for BRAF Mutations in Patients with Melanoma

(Yahoo! Finance) July 14, 2015 - New test provides physicians with a liquid biopsy option to reach informed treatment decisions for patients with melanoma and other tumors.
read article 

July 2015 Decisions News Release

(Scottish Medicines Consortium) July 13, 2015 - The Committee was unable to recommend two other medicines considered under the PACE process, olaparib (Lynparza) for ovarian cancer and vinflunine (Javlor) for cancer of the bladder and the urinary tract.
read press release 

QIAGEN Companion Diagnostic Wins FDA Approval For Use With IRESSA

(QIAGEN) July 13, 2015 - therascreen® EGFR RGQ PCR Kit to guide treatment with AstraZeneca’s lung cancer drug in U.S.
read corporate press release 

Cleave Biosciences Gets FDA Orphan Status For CB-5083 To Treat Multiple Myeloma

(Pharmaceutical Business Review) July 14, 2015 - US-based biopharmaceutical firm Cleave Biosciences has received orphan drug designation from the US Food and Drug Administration (FDA) for its lead drug candidate, CB-5083, to treat multiple myeloma.
read article 

Cancer Spread 'Lynchpin’ Identified

(Yahoo! News [UK & Ireland]/Press Association) July 13, 2015 - A molecule described as the "lynchpin" of cancer spread has been identified, paving the way to potentially life-saving treatments.
read article 

Celator® Pharmaceuticals Announces Start of Clinical Study of CPX-351 in Acute Myeloid Leukemia Patients at High Risk for Induction Mortality

(TheStreet) July 14, 2015 - Celator Pharmaceuticals, Inc. today announced that patients have been enrolled in an investigator-initiated Phase 2 clinical study evaluating CPX-351 (cyatarabine:daunorubicin) Liposome Injection as a treatment for patients with newly diagnosed Acute Myeloid Leukemia (AML) at high risk for induction treatment mortality.
read article 

Young Adult Cancer Survivors More Likely to Be Hospitalized

(U.S. News & World Report/HealthDay News) July 13, 2015 - Young adult cancer survivors are more likely to be hospitalized than people who never had cancer, a new study finds.
read article 

New Drug Combo Could Make Cancer More Sensitive To Chemo

(Cancer Research UK) July 13, 2015 - Combining chemotherapy with new drugs that target a protein that helps cancer cells to withstand chemotherapy could drastically improve treatment, according to research published in the journal Cancer Cell.
read press release 

New Surgical Technique Preserves Kidney Function Following Tumour Removal

(MedUni Vienna [Austria]) July 13, 2015 - A surgical method for renal cell carcinoma that preserves long-term renal function has now been carried out successfully for the first time in the University Department of Urology at the MedUni Vienna and Vienna General Hospital.
read press release 

Online Registry Improves Clinical Research Study Participation

(Cedars-Sinai) July 13, 2015 – Research for Her™, Cedars-Sinai’s groundbreaking online registry that matches women with research studies and clinical trials, enrolled study participants more quickly when compared with traditional paper-based registries, according to new research published in the journal Gynecologic Oncology.
read press release 

Peeking Into The Genome Of A Deadly Cancer Pinpoints Possible New Treatment

(Stanford Medicine/Scope blog) July 13, 2015 - Little is known about the molecular causes of small cell lung cancer, and no new treatments have been approved by the Food and Drug Administration since 1995.
read article 

Lung Cancer Patients Who Stop Smoking Live Longer

(RPCI) July 13, 2015 - Tobacco cessation provided significant survival benefit for lung cancer patients who quit smoking shortly before or after diagnosis, despite the severity of the disease. Results of the Roswell Park Cancer Institute study were published in the Journal of Thoracic Oncology.
read press release 

Study Links Leisure Time Sitting to Higher Risk of Specific Cancers

(American Cancer Society) July 13, 2015 - Spending more leisure time sitting was associated with a higher risk of total cancer risk in women, and specifically with multiple myeloma, breast, and ovarian cancers, according to a new study.
read press release 

Cancers Caught During Screening Colonoscopy Are More Survivable

(ASGE) July 13, 2015 – Patients whose colorectal cancer (CRC) is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
read press release 

Gefitinib (Iressa) Back in the US for Lung Cancer, Now as First-Line

(Medscape Medical News) July 13, 2015 - The US Food and Drug Administration today announced the approval of gefitinib (Iressa, AstraZeneca) for the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) whose tumors contain specific types of epidermal growth factor receptor (EGFR) gene mutations.
read article (free registration required) 

Liquid Biopsy Identifies Mutations In Colorectal Cancer That Go Undetected In Tissue Biopsy

(Vall d'Hebron Institute of Oncology [Barcelona, Spain]) July 14, 2015 - The CORRECT study, published ahead of print online today in The Lancet Oncology, is one of the largest trials to date comparing data provided by liquid versus tissue biopsy in metastatic colorectal cancer patients.
read press release 

FDA Approves Targeted Therapy For First-Line Treatment Of Patients With A Type Of Metastatic Lung Cancer

(FDA) July 13, 2015 - The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
read press release 

Prenatal Tests Can Now Reveal Whether A Mom-To-Be Has Cancer

(Washington Post/Wonkblog) July 13, 2015 - A study published Monday in the Journal of the American Medical Association describes the cases of Danielle Bryant and nine other women who received abnormal prenatal test results that turned out to flag their own cancer.
read article (free registration required) 

Obamacare Flexes Muscles With New Medicare Payment Plans

(New York Times/The Upshot) July 10, 2015 - For the first time, the Obama administration has deployed an important new power it has under the Affordable Care Act: proposing to pay doctors and hospitals based on the quality of care they provide, regardless of whether they want to be paid that way.
read article 

FDA Approves Otsuka And Lundbeck's Schizophrenia Treatment

(Reuters) July 10, 2015 - The U.S. Food and Drug Administration approved Danish drugmaker H. Lundbeck A/S and Japan's Otsuka Pharmaceutical Co Ltd's Rexulti, an anti-psychotic drug used to treat schizophrenia.
read article 

Pricey Successor Overtakes $1,000-Per-Pill Hepatitis C Drug

(Fox News/Associated Press) July 13, 2015 - The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors. The new leading pill for hepatitis C is more expensive, and the number of patients seeking a cure has surged.
read article 

Should Doctors And Drugmakers Keep Their Distance?

(NPR/Shots blog) July 12, 2015 - One doctor rethinks his hardline stance against contact with industry. Beyond drugmakers' sales and marketing, perhaps there's room for productive and ethical collaboration to advance medicine.
read article 

House Passes Bill to Improve Safety Monitoring of Medical Devices

(Wall Street Journal) July 12, 2015 - A sweeping medical research bill that passed the House on Friday included a provision aimed at improving safety monitoring of medical devices—an amendment inspired by a controversial gynecological device.
read article (paid subscription required) 

NDSU Researcher To Study Flaxseed As Lung Cancer Prevention

(Grand Forks Herald [Grand Forks, ND]) July 13, 2015 - Could flaxseed, a top North Dakota crop, help prevent lung cancer? A North Dakota State University researcher aims to find out.
read article 

Nintendo President’s Death Highlights Risk of Rare Cancer Type

(Bloomberg) July 13, 2015 - Nintendo Co. President Satoru Iwata died over the weekend of bile duct cancer, 13 months after he underwent surgery to remove a growth from his biliary tract.
read article